Anixa Biosciences, Inc. (ANIX)
Health Care ยท Pharmaceutical Preparations
Anixa Biosciences, Inc. (ANIX) is listed on Nasdaq, where its shares have traded since October 7, 1983. SentiSense covers Anixa Biosciences, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. The company reports 4 employees, and its corporate website is www.anixa.com.
About Anixa Biosciences, Inc.
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Latest reported results
Anixa Biosciences, Inc. reported revenue of $0.00 for Q3 FY2026.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 58 institutions reported holding ANIX, with 5.3 million shares worth $14.8 million in aggregate. The largest reported holders were Vanguard, UBS Group and Laird Norton Wetherby Trust Company. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on ANIX
- ANIX sentiment: whether news and social coverage of Anixa Biosciences, Inc. leans bullish or bearish, and the stories driving it.
- ANIX ownership: all 58 reporting institutions, plus insider and congressional trades.
- ANIX financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does Anixa Biosciences, Inc. do?
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology.
What sector is ANIX in?
SentiSense classifies Anixa Biosciences, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ANIX stock trade?
Anixa Biosciences, Inc. (ANIX) is listed on Nasdaq, where its shares have traded since October 7, 1983.
How many institutions own ANIX?
58 institutions reported a position in ANIX in 13F filings for the quarter ended June 30, 2026, worth $14.8 million in total.